home / stock / xbio / xbio short
Short Information | Xenetic Biosciences Inc. (NASDAQ:XBIO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 39,749 |
Total Actual Volume | 152,902 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 1 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 1,987 |
Average Short Percentage | 21.19% |
Is there a XBIO Short Squeeze or Breakout about to happen?
See the XBIO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-22-2024 | $4.06 | $3.76 | $4.1 | $3.76 | 7,200 | 129 | 1.79% |
04-19-2024 | $3.98 | $4.2 | $4.2 | $3.98 | 767 | 200 | 26.08% |
04-18-2024 | $3.92 | $4.14 | $4.39 | $3.92 | 7,906 | 5,309 | 67.15% |
04-17-2024 | $4.2999 | $3.86 | $4.2999 | $3.8125 | 2,773 | 156 | 5.63% |
04-16-2024 | $3.91 | $4.015 | $4.015 | $3.82 | 2,611 | 352 | 13.48% |
04-15-2024 | $4.11 | $4.14 | $4.315 | $4.11 | 9,138 | 1,259 | 13.78% |
04-12-2024 | $4.46 | $4.33 | $4.46 | $4.33 | 1,419 | 2 | 0.14% |
04-11-2024 | $4.56 | $4.4292 | $4.56 | $4.3401 | 7,140 | 660 | 9.24% |
04-10-2024 | $4.64 | $4.6859 | $4.6859 | $4.64 | 5,272 | 202 | 3.83% |
04-09-2024 | $4.66 | $4.72 | $4.73 | $4.65 | 1,528 | 130 | 8.51% |
04-08-2024 | $4.62 | $4.65 | $4.74 | $4.62 | 3,917 | 389 | 9.93% |
04-05-2024 | $4.48 | $4.63 | $4.6399 | $4.4105 | 2,487 | 1,200 | 48.25% |
04-04-2024 | $4.71 | $4.4001 | $4.71 | $4.4001 | 3,481 | 336 | 9.65% |
04-03-2024 | $4.39 | $4.62 | $4.64 | $4.31 | 31,818 | 8,524 | 26.79% |
04-02-2024 | $4.15 | $4.39 | $4.467 | $4.15 | 20,170 | 6,235 | 30.91% |
04-01-2024 | $3.8059 | $4.2 | $4.2 | $3.8059 | 18,346 | 7,947 | 43.32% |
03-28-2024 | $3.8965 | $3.77 | $3.8999 | $3.77 | 3,948 | 1,136 | 28.77% |
03-27-2024 | $3.96 | $3.98 | $4.17 | $3.96 | 9,311 | 3,644 | 39.14% |
03-26-2024 | $3.99 | $3.82 | $4 | $3.77 | 4,818 | 1,631 | 33.85% |
03-25-2024 | $3.76 | $3.95 | $4 | $3.75 | 8,852 | 308 | 3.48% |
News, Short Squeeze, Breakout and More Instantly...
Xenetic Biosciences Inc. Company Name:
XBIO Stock Symbol:
NASDAQ Market:
Xenetic Biosciences Inc. Website:
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the year with $9.0 million of cash to fund operations FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 /...
- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platform FRAMINGHAM, MA / ACCESSWIRE / January 17, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advan...
Encouraging growing body of preclinical data guiding pathway to first in human trial for DNase-based oncology platform Driving development towards Phase 1 program for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Continuing partnering discus...